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Cosby et al. (6) have recently shown that infusion of nitrite at low concentration into the forearm of volunteers results in increased blood flow. In addition, they found that in vitro relaxation of aortic rings by nitrite was enhanced by free Hb plus inosine hexaphosphate and by RBCs.
Previous studies have found that supraphysiological concentrations (in mM) of nitrite generate NO in the pulmonary circulation, particularly when the lung is exposed to hypoxia or hypercapnia (1, 2, 15) . High concentrations of nitrite also have pharmacological effects in the lung; Hunter et al. (22) found that inhaled nebulized nitrite reduced pulmonary artery pressure during hypoxia-and thromboxane-induced pulmonary hypertension in newborn lambs (22) . Plasma nitrite concentrations in this study were in the range of 20 -30 M compared with physiological concentrations of Ͻ1 M in humans and other mammals (14) .
Nitrite reduction to NO by deoxyHb in the lung might result in inhibition of hypoxic pulmonary vasoconstriction (HPV) and impair gas exchange. In the current work, we sought to determine whether low concentrations of nitrite, approaching physiological levels, can generate NO and inhibit HPV in isolated, perfused rat lungs. In addition, we sought to determine whether any inhibition of HPV by nitrite was potentiated by acidosis, the enzyme XO, or RBCs and whether the rate of nitrite degradation was affected by the presence of RBCs in our model.
MATERIALS AND METHODS
The Animal Care Committees of the Veterans Affairs Puget Sound Health Care System and the University of Washington approved the protocol.
Hb and RBC Preparation, and Measurement of Exhaled NO and Perfusate Nitrite
Reagents. All reagents were purchased from Sigma Chemical (St. Louis, MO), unless otherwise noted.
Hb preparation. OxyHb was prepared from fresh human blood as previously described and frozen at Ϫ80°C for later use. Spectrophotometrically derived metHb concentration was Ͻ1% before addition to the lung perfusate.
RBC preparation. Fresh blood was obtained from anesthetized study and donor rats via cardiac puncture and centrifuged at 2,500 rpm, and the plasma and buffy coat was discarded. RBCs were then washed three times in cold phosphate-buffered saline and stored on ice until 5 min before addition to the perfusate, at which time they were warmed to 37°C in a water bath.
Measurement of NO and nitrite.
Exhaled NO was measured continuously using a chemiluminescence detector with the sampling line positioned within the expiratory limb of the ventilatory circuit.
Perfusate nitrite concentrations were measured by chemiluminescence after reduction to NO as previously described (6) .
Measurement of free Hb. In a 1-ml cuvette, 200 l of the perfusate sample were mixed with 800 l of Drabkin's reagent. After 15 min at room temperature, the absorbance was measured at 540 nm. The concentration of Hb was determined using the following equation: A 540 ϫ dilution factor/11 (extinction coefficient) ϫ 4 ϭ Hb (in mM).
Experimental preparation. The isolated, perfused, lung model has been previously described by ourselves and others in detail (12) . Briefly, adult Sprague-Dawley rats weighing 300 -500 g were anesthetized with intraperitoneal pentobarbital sodium, a tracheotomy was established, and mechanical ventilation was initiated with a mixture of 21% O 2-6% CO2-73% N2, using a respiratory rate of ϳ40 breaths/min and a peak airway pressure of ϳ10 cmH 2O. Heparin (300 units) was administered by intracardiac injection, and the pulmonary artery and left atrium were cannulated in situ and the lungs flushed of blood by slow perfusion with a Masterflex pump (Cole-Palmer, Barrington, IL). After the lungs were flushed, a recirculating circuit was established with a total circuit volume of 19 ml at a constant flow of 15 ml/min. The heart and lungs remained in situ throughout the experiments and were covered with plastic wrap to maintain temperature and humidity. The perfusate consisted of buffered crystalloid solution containing (in mM) 11 D-glucose, 1.2 MgSO4, 1.2 KH2PO4, 4 KCl, 118 NaCl, 2.5 CaCl2, and 25 NaHCO3 and 4% Ficoll as colloid. Meclofenamate (3.1 M) was added to the perfusate to prevent any effects of eicosanoids on vascular tone or the stability of the preparation. Perfusate pH was maintained at 7.35-7.45 by addition of NaHCO3 as needed. Left atrial pressure was maintained constant at 2 Torr by a screw clamp on the outflow circuit, and perfusate temperature was maintained at 38°C (38.5 Ϯ 0.5). Preparations were allowed to stabilize for 10 -15 min before any experimental interventions.
Pulmonary artery pressure (PAP) and left atrial pressure were measured via small-bore tubing that was positioned internally at the ostia of the perfusion cannulae. Pressure data were continuously recorded using an analog-to-digital (A-D) converter, data acquisition software (AD Instruments, Colorado Springs, CO), and a personal computer (Macintosh, Cupertino, CA). Perfusate PO2, PCO2, and pH were measured by using a conventional blood-gas machine (Radiometer, Copenhagen, Denmark).
Experimental Protocols
General. Unless otherwise specified, after an initial period of stabilization, the L-arginine analog N -nitro-L-arginine methyl ester (L-NAME; 100 M) was added to the perfusate to inhibit endogenous NO production and to augment the hypoxic pressor response; the effectiveness of this intervention was documented in a small series of experiments by measuring the increase in PAP during hypoxia before and after L-NAME administration. For all other experiments, the baseline pressor response to hypoxia (HPV) after L-NAME was established by ventilating the lungs with hypoxic, normocarbic gases [inspired O2 fraction (FIO 2 ), 0 -0.05; inspired CO2 fraction (FICO 2 ), 0.05; and balance N2] for 5 or 10 min (hypoxia), with pulmonary artery pressure recorded before and at the completion of hypoxic ventilation. Hypoxic ventilatory challenges were separated by 5-to 15-min periods of normoxic ventilation. Perfusate samples for the measurement of nitrite were obtained throughout individual experiments and flash frozen for later analysis; in RBC-perfused experiments, samples were centrifuged and the supernatant frozen.
Experimental protocol: buffer-perfused lungs. After a baseline hypoxic pressor response by ventilation with anoxic gas was established, repeated 5-min hypoxic ventilatory challenges were performed, starting 2 min after addition of sodium nitrite (in increasing perfusate concentrations ranging from 250 nM to 1 mM) or saline vehicle (controls). In a subset of experiments, hypoxic challenges were alternated with 5-min periods of anoxic ventilation with the addition of 10% CO2 to produce acidosis (hypoxia plus acidosis). In another subset of experiments, free Hb at concentrations of 10 -30 M was added to the perfusate. Inosine hexaphosphate (25-100 M) was also added to the perfusate to promote Hb deoxygenation in some experiments. Repeated trials of anoxic ventilation were performed at baseline and after an addition of concentrations of sodium nitrite (1-30 M) or saline vehicle (controls), and perfusate samples were saved for later analysis.
To determine whether nitrite reduction in buffer-perfused lungs was facilitated by intrinsic XO, the competitive XO inhibitor oxypurinol was added at a concentration of 500 M to the perfusate following an addition of 20 M nitrite. After a 10-min stabilization period with normoxic ventilation, anoxic ventilation was initiated for 5 min.
To further characterize the role of XO in nitrite reduction during buffer perfusion, exogenous XO was added to the perfusate at a concentration of 0.025 U/ml at the initiation of buffer perfusion. To ensure that any effect on HPV by XO was due to nitrite reduction rather than superoxide generation, SOD was also added to the perfusate at a concentration of 75 U/ml. After a 10-min stabilization period with normoxic ventilation, anoxic ventilation was initiated for 10 min, with HPV quantitated at 5 and 10 min. This protocol was repeated after an addition of nitrite (at concentrations of 1-20 M) or saline vehicle to the perfusate.
Experimental protocol: RBC-perfused lungs. These experiments were conducted similar to those described in Experimental protocol: buffer-perfused lungs, with the exception that washed RBCs were added to the perfusate to achieve Hct values of ϳ1% or 15% after L-NAME addition. Repeated hypoxic ventilatory challenges were performed in the absence of nitrite (baseline) and in the presence of increasing perfusate concentrations of nitrite, from 1-40 M or saline vehicle (control). In addition, several subgroups were studied, as follows. First, the FIO 2 during hypoxic ventilation was varied between 0, 0.03, or 0.05. Second, the timing of nitrite addition to the perfusate was varied between 2 and 15 min before hypoxic ventilation. Finally, a subgroup of experiments was conducted in the absence of L-NAME administration. Perfusate samples from RBC experiments were stored and analyzed for free Hb concentration at a later date (as a measure of RBC hemolysis).
Experimental protocol: nitrite degradation studies. To determine the effects of hypoxia and RBCs on the rate of nitrite degradation, nitrite was added to the perfusate of buffer or RBC-perfused lungs (Hct, ϳ15%) at a concentration of ϳ10 M. The lungs were ventilated with either normoxic (FIO 2 , 0.21%) or hypoxic gas (FIO 2 , 0 for buffer-perfused lungs; and FIO 2 , 0.03 for RBC-perfused lungs) for 20 min. Perfusate samples were taken and flash frozen at 5 min intervals; for RBC-perfusates, samples were centrifuged and the supernatant was frozen. Samples were later assayed for nitrite concentration using chemiluminescence, as described above.
Analysis and Statistics
Data were only analyzed from experiments with an initial baseline hypoxic pressor response of Ն2 mmHg, since subsequent inhibition of HPV is impossible to assess in the absence of a positive baseline response.
Analysis was done using software programs Excel (Microsoft, Redmond, WA), StatView (SAS Institute, Cary, NC), and Prism (GraphPad Software, San Diego, CA) on Apple Computers (Apple Computer, Cupertino, CA). Data are presented as means (SD). Statistical analysis was done using paired t-tests for within-group comparisons, unpaired t-tests for between-group comparisons, and repeated-measures analysis of variance for comparison of time-group interactions. For between-group (nitrite vs. control) comparisons, hypoxic challenges were matched by time and number of challenge. This was necessary to control for the observation that HPV generally increases with repeated challenges and over time. Nitrite degradation between different conditions and over time was tested using paired t-tests for within-group differences and repeated-measures analysis of variance to detect differences between groups over time. A P value Ͻ 0.05 was accepted as statistically significant.
RESULTS

Inhibition of HPV by Nitrite in Buffer-Perfused Lungs
In buffer-perfused lungs, normoxic PAP was higher in control lungs, but the baseline hypoxic pressor response was similar between study and control groups (Table 1 and Fig. 1 ). Nitrite addition resulted in dose-dependent inhibition of HPV at concentrations of ϳ7 M and above (Fig. 1A) , an effect that was prevented by concentrations of free Hb (30 M) that were equal to or greater than the perfusate nitrite concentration. Additional studies found no inhibition of HPV by nitrite at concentrations of ϳ3 M or less (data not shown). The addition of hypercapnic acidosis to hypoxia did not potentiate inhibition of HPV by nitrite (Fig. 1B) ; this was true for buffer or buffer plus Hb (data not shown). Inhibition of HPV by nitrite in buffer-perfused lungs was not reversed by oxypurinol (data not shown). XO plus nitrite did not potentiate reduction of HPV by nitrite (Fig. 1C) . Addition of XO to buffer perfusate had no significant effect on HPV in the absence of nitrite (data not shown). Excess nitrite inhibited HPV in the presence of low concentrations of free Hb (10 M) (Fig. 1D) .
Addition of RBCs to the Perfusate
Baseline characteristics of RBC-perfused lungs are shown in Table 1 ; normoxic PAP was slightly higher in the control group perfused with 15% Hct and ventilated with anoxic gas, but otherwise there were no significant differences between groups. When perfusate Hct was ϳ15%, hypoxic PAP was not affected by the presence of nitrite up to ϳ25 M compared with time-matched controls. This was true whether the ventilation gas contained 0% ( Fig. 2A), 3% (Fig. 2C ), or 5% (data not shown) O 2 . This is in contrast to significant reduction of anoxic PAP by sodium nitroprusside at 1 M compared with nitrite at 25 M (Fig. 2B) . Addition of nitrite to the perfusate 15 min before initiation of hypoxia had no effect on HPV (Fig.  2C) ; this should have provided more than ample time for equilibration between extra-and intracellular nitrite concentrations (24) . In contrast, when perfusate Hct was 1-2%, sodium nitrite resulted in dose-dependent reduction in hypoxic PAP compared with controls without nitrite (Fig. 2D) . The omission of L-NAME from the perfusate had no effect on the lack of inhibition of HPV by nitrite in lungs perfused with 15% Hct (data not shown).
Perfusate free Hb (due to RBC hemolysis) at the conclusion of a series of 1% Hct experiments was 4.0 M (SD 3.8) (n ϭ 9) and at the conclusion of a series of 15% Hct experiments was 13.5 M (SD 3.4) (n ϭ 15).
Effect of Nitrite Addition on Exhaled NO
Exhaled NO during normoxic conditions in buffer-perfused lungs was 5.5 parts/billion (SD 0.6). Exhaled NO did not change after an addition of 20 M nitrite or less to the perfusate, during either normoxia or hypoxia. However, after an addition of nitrite (1 mM) to the perfusate, exhaled NO increased by 3.8 parts/billion (SD 0.8) (P Ͻ 0.001), increased further during hypoxia by 15.1 parts/billion (SD 3) (P Ͻ 0.001 vs. normoxia), and further yet during combined hypoxia and acidosis (P ϭ 0.02 vs. hypoxia) (Fig. 3A) . Exhaled NO fell with the resumption of normoxic ventilation after hypoxia or hypoxia plus acidosis, although after 5 min, it had not quite returned to the previous normoxic value. In lungs perfused with buffer containing RBCs, there was no change in exhaled NO under any of the conditions studied (data not shown).
Perfusate Nitrite Concentrations Under Various Conditions
In normoxic conditions, perfusate nitrite concentrations did not change significantly in either buffer-or RBC-perfused lungs over 20 min of perfusion (Fig. 3B ). Hypoxia did not significantly effect perfusate nitrite levels over 20 min compared with normoxia in buffer-perfused lungs, whereas hypoxia in the presence of RBCs resulted in a fall in nitrite concentration compared with normoxia (P ϭ 0.04, normoxia vs. hypoxia) (Fig. 3B) . The behavior of nitrite concentration over time was significantly affected by perfusate composition during hypoxic ventilation (P ϭ 0.0003, buffer vs. RBCs) (Fig. 3B) .
Plasma nitrite in whole blood from healthy, untreated rats was 213 nM (SD 53) (n ϭ 8).
DISCUSSION
Over the past decade, considerable research and debate have been devoted to the mechanism(s) by which RBCs might participate in NO biology and vascular control, beyond simple oxidation and inactivation of NO by Hb leading to vasoconstriction. In particular, it has been hypothesized that RBCs may generate NO in response to hypoxia, thereby acting as modulators of "hypoxic vasodilation" in the systemic circulation. The first such hypothesis suggested that NO bound to a cysteine residue on the ␤-chain (␤-93) of Hb [S-nitrosoHb (SNO-Hb)] was under allosteric control, with SNO-Hb formation favored when Hb is oxygenated and release of SNO/NO occurs as Hb deoxygenates (26, 32, 39) . The second major hypothesis suggests that nitrite within plasma and RBCs is a NO reservoir and that NO production from nitrite is allosterically catalyzed by deoxyHb, which acts as a nitrite reductase that is most effective near the P 50 (6, 19, 21) . The merits of these two hypotheses and their roles in hypoxic vasodilation have been debated at length elsewhere (17, 18, 31, 38) . There has been little research into the effects of either SNO-Hb or nitrite on the pulmonary circulation; the remainder of this discussion will focus on the role of the RBC in modulating HPV, particularly in regard to Hb-NO interactions.
It has long been recognized that RBCs augment HPV (recently reviewed) (8) , with new evidence suggesting that the predominant mechanism for this is NO oxidation and inactivation by Hb to form metHb and nitrate (10, 13) . Thus the notion that RBCs may release NO in response to hypoxia and thereby blunt the HPV response is somewhat counterintuitive. In regard to SNO-Hb, this paradox can be reconciled by the proposed mechanism of binding and release of SNO/NO to Hb, with SNO-Hb formation favored during oxygenation in the lung and with SNO/NO release favored during deoxygenation in the systemic vascular bed, with the greatest amount of SNO released in the most hypoxic tissues. Because deoxygenated blood is returned to the lung and undergoes oxygenation, there will be NO uptake and SNO formation since the PO 2 of pulmonary arterial blood comes into equilibrium with alveolar gas. Thus, in theory, the SNO-Hb hypothesis is consistent with the known salutary effects of RBCs on HPV in that SNO-Hb would not release NO and act to impair HPV during hypoxic conditions, since NO would be taken on by Hb during O 2 loading. However, this may not be true if RBC-mediated generation of NO from nitrite is physiologically relevant. Since there is a continuous pool of circulating nitrite produced from NO oxidation in the systemic and pulmonary circulations, the nitrite reductase capacity of Hb to produce NO would potentially be operant as long as Hb is deoxygenated, including in the pulmonary arterial bed, albeit at a slower rate since the amount of deoxyHb declines during blood transit through the pulmonary microvasculature. In turn, the generation of NO by RBCs might lead to inhibition of HPV [a critical mechanism of ventilation-to-perfusion ratio (V A /Q) matching], resulting in a cycle of worsening hypoxia and increased NO generation from nitrite. Thus the effects of nitrite, particularly within the physiological range on HPV, are of great importance in understanding the role of nitrite and RBCs in vascular control.
In the present study, we make several important and novel observations that add to our understanding of the role of nitrite and RBCs in NO biology and modulation of HPV. First, we present evidence that low concentrations of nitrite can inhibit HPV during mild hypoxia in buffer-perfused lungs, although inhibitory concentrations (Ն5 M) remain considerably higher than those circulating in the blood of healthy humans or other mammals. For example, in the current study, we measured rat plasma nitrite concentrations of ϳ200 nM, and other investigators have measured blood nitrite concentrations of Ͻ1 M in humans. Second, we confirm that high-nitrite concentrations generate NO in buffer-perfused lungs, an effect that is potentiated by mild hypoxia and hypercapnic acidosis as seen by others (1, 2, 15) . Third, we demonstrate that nitrite consumption is significantly potentiated by hypoxia when RBCs are present, lending credence to the theory that RBC deoxyHb acts as a nitrite reductase that is most effective near the P 50 of Hb. Finally, we show that despite increased nitrite consumption (and presumed NO generation) during perfusion with RBCs, high concentrations of RBCs (and free Hb) prevent inhibition of HPV by nitrite at concentrations that are inhibitory in the absence of RBCs. Each of these observations will be discussed below.
Inhibition of HPV and NO Generation by Nitrite in Buffer-Perfused Lungs
Previous investigators have documented NO production from nitrite at concentrations of 100 M and above in isolated, buffer-perfused lungs (1, 15) . These results were presumed to reflect the slow rate of release of free NO from nitrite in solution. We were unable to document NO production from nitrite as reflected in exhaled NO changes when perfusate concentrations were 30 M or less; however, exhaled NO from the rat lung does not appear to be particularly sensitive to changes in perfusate NO concentration. In a previous study, sodium nitroprusside at a concentration of 10 M resulted in only a minimal increase in exhaled NO, and there was no effect of 20 M S-nitrosoglutathione on exhaled NO despite Hbinhibitable vasodilation at this concentration (11) . Thus it is likely that nonenzymatic degradation of nitrite results in physiologically significant free NO production in the isolated, perfused rat lung. . Perfusate Hct and inspired O2 fraction (FIO 2 ) were varied to explore the effect of these factors on vascular relaxation by nitrite. A: RBCs were added to achieve a perfusate Hct of ϳ15%, and sodium nitrite was added 2 min before initiating ventilation with anoxic gas (n ϭ 6). B: PAP after 5 min of ventilation with anoxic gas in lungs perfused with 15% Hct in the presence of sodium nitrite (25 M) or SNP (1 M) (n ϭ 10 experiments). C: lungs were perfused with buffer containing RBCs at Hct 15%; sodium nitrite was added 15 min before initiating ventilation with gas containing 3% O2 (n ϭ 10 experiments). D: RBCs were added to achieve a perfusate Hct of ϳ1-2%. Sodium nitrite was added 15 min before initiating ventilation with gas containing 3% O2. Nitrite resulted in dose-dependent reduction of hypoxic PAP (n ϭ 5-9 experiments). *P Ͻ 0.05 vs. control; **P Ͻ 0.01 vs. control.
Nitrite at a mean perfusate concentration of 7 M reduced HPV in buffer-perfused lungs. This is consistent with previous findings of an EC 50 for nitrite of 4.5 M for relaxation of pig pulmonary artery rings (15) . Attenuation of HPV by nitrite was inhibited by excess free Hb (Fig. 1A) and by RBCs (15% Hct) (Fig. 2) , which provides indirect evidence that vasorelaxation by nitrite is indeed mediated by free NO. Although it is possible that nitrite resulted in direct pulmonary vasodilation as suggested by other investigators (15) , this would be difficult to reconcile with the inhibition of effect by free Hb and RBCs seen in our model. Lastly, free Hb did not potentiate inhibition of HPV by nitrite in our model, which might be expected if a "deoxyreductase" function of Hb was dominant over the oxidative reaction of NO with Hb in vivo.
Acidosis increases reduction of nitrite to NO through nonenzymatic disproportionation (41): NOOH ϩ NO 2 Ϫ 7 NO ϩ NO 2 . In addition, Agvald et al. (2) have shown in an isolated lung model that hypercapnia promotes NO generation from nitrite that does not appear to be pH dependent. However, in the current study, reduction in HPV by nitrite was not potentiated by hypercapnic acidosis (Fig. 1B) , despite evidence that hypercapnia increased NO generation in the presence of high-nitrite concentrations (Fig.  3A) . It may be that the pH change elicited in the current work (from ϳ7.4 to 7.2) was insufficient to promote significant additional nonenzymatic NO production from low concentrations of nitrite. However, this pH is consistent with that seen under physiological conditions and gives some insight into the role of acidosis on NO generation from nitrite in vivo. Previous in vitro studies describing acidic disproportionation have shown significant NO generation only with pH Ͻ 6 and at higher nitrite concentrations (37, 42) . Likewise, potentiation of NO production from nitrite by hypercapnia was studied only at a nitrite concentration of 1 mM (2) .
XO has been shown to reduce nitrite to NO in previous in vitro work, in both normoxic and hypoxic conditions (40) . However, we were also unable to document a contribution of either endogenous or exogenous XO on nitrite inhibition of HPV in our model. This may again be related to a concentration effect of nitrite; Zhang et al. (40) found that in vitro NO production from nitrite in the presence of XO (0.025 U/ml) was concentration dependent, with minimal effect at Ͻ1 mM nitrite.
The most important findings in the current study relate to the effect of RBCs on nitrite consumption and pulmonary vascular tone during hypoxia. We clearly demonstrate that nitrite degradation during hypoxia is accelerated by the presence of RBCs (Fig. 3B) , a finding that is consistent with previous in vitro descriptions of the nitrite reductase property of deoxyHb (16, 20, 21, 34) . In this reaction, nitrite reacts with deoxyHb plus a proton to form NO and metHb, as illustrated by this simplified equation:
It is unclear as to how any free NO generated avoids further reaction with Hb(II) to form Hb(II)NO (nitrosylHb), a product that releases NO only very slowly. In addition, it has been proposed that the reaction of nitrite with Hb may not produce free NO, and the precise mechanism by which nitrite-related NO bioactivity may be exported from Hb within the RBC to the vascular site of action is unclear at this point. Proposed mechanisms include generation of S-nitrosothiols or other intermediates (3, 35, 36) .
Our finding that nitrite degradation is accelerated by hypoxia in the presence of RBCs is in contrast to our previous observations using SNO-Hb and SNO-Hb-loaded RBCs in similar models, where we were unable to document any effect of hypoxia on SNO loss from Hb or RBCs in the pulmonary circulation (10 -12) . Thus our work supports the hypothesis that RBCs have the potential to contribute to hypoxic vasodilation in the systemic circulation through NO production from nitrite and do so in an ex vivo lung model that more closely approximates physiological conditions than the static, systemic vascular ring models used by previous investigators.
However, despite potentiation of nitrite degradation during hypoxia by RBCs, concentrations of RBCs that approach physiological levels nevertheless prevented attenuation of HPV by nitrite concentrations that were inhibitory in buffer-perfused lungs (Figs. 1 and 2 ). RBCs were subjected to PO 2 values that span the P 50 for rat Hb (35) (36) (37) (38) , the predicted point of maximal nitrite reductase activity for deoxyHb (20, 21) . In addition, exposure time to nitrite failed to reveal a pulmonary vasodilator effect of nitrite in the presence of RBCs. This contrasts with previous in vitro work showing RBC-potentiated aortic smooth muscle relaxation by low concentrations of nitrite and increased forearm blood flow during nitrite infusion in human subjects (6) .
The disagreement between our findings in a lung model and previous work showing reduction in hypoxia-induced pulmonary artery hypertension by inhaled, nebulized nitrite in newborn lambs can be explained by the high intrapulmonary concentrations of nitrite achieved by inhalation therapy, with a conservative estimate of the epithelial lining fluid concentration of 7 mM based on the administered nitrite dose (4, 5) . The pulmonary vascular smooth muscle was thus exposed to a nitrite concentration somewhere between the estimated alveolar concentration and the more modest measured arterial plasma concentrations (20 -30 M) (22) . In addition, it is notable that these systemic nitrite concentrations were insufficient to evoke a reduction in systemic arterial blood pressure compared with that of hypoxic controls in this study, despite the ideal milieu for doing so (arterial oxygen saturation of ϳ55%). This latter observation raises the question as to whether nitrite at low concentrations does in fact play an important role in hypoxic vasodilation.
Other explanations for differences in our findings in the pulmonary circulation and evidence of vascular relaxation of systemic vessels by nitrite in the presence of RBCs both in vitro and in vivo may be explained in several ways. First, the hypoxic pulmonary circulation may be more resistant to NOmediated vasodilation than the hypoxic systemic circulation, and lower concentrations of NO may be sufficient to relax systemic vascular smooth muscle given the comparatively high intrinsic tone and an intrinsic vasodilatory response to hypoxia. However, this does not provide a likely explanation for our findings, given that nitrite did inhibit HPV in buffer-perfused lungs, whereas a modest concentration of RBCs prevented this effect. This suggests that the net effect of RBCs in the presence of nitrite was the inactivation rather than the generation of NO. Second, the NO generated by RBCs was inactivated by perfusate-free Hb present as a result of hemolysis in our model. However, this seems quite unlikely since nitrite remained an effective vasodilator when added in excess of Hb in bufferperfused lungs (Fig. 1D ) and in lungs perfused with a low concentration of RBCs with an associated low level of perfusate-free Hb (Fig. 2D) . Third, NO generated by deoxyHb reduction of nitrite does not escape the RBC due to oxidation/ inactivation by oxyHb, which remains present in significant quantity in partially deoxygenated blood. In fact, the rate constant of the oxyHb-NO reaction is seven orders of magnitude faster than that of the deoxyHb-nitrite reductase reaction (23) . The critical balance of NO generation and NO scavenging appears to be determined by the ratio of nitrite to Hb, such that NO inactivation dominates when Hb is in excess (7) . This reality is supported by our observation that both RBCs and free Hb barely in excess of nitrite prevent inhibition of HPV by nitrite, suggesting that free NO generated from nitrite is quickly scavenged by oxyHb. However, when nitrite was present in excess of Hb, nitrite acted as a vasodilator, presumably by generating NO (Fig. 1D) . Note that in normal physiological conditions, Hb is always far in excess of nitrite, with an effective molar Hb concentration in whole blood of Ͼ2 mM compared with nitrite concentrations of Ͻ1 M (14) .
When the RBC concentration in the perfusate was reduced to subphysiological concentrations (Hct of 1-2%), Hb remained in excess of nitrite (ϳ51 M vs. a peak nitrite concentration of ϳ37 M), but nitrite reduced hypoxic PAP compared with control experiments (Fig. 2D) . This illustrates the dose-dependent effect of RBC concentration on hypoxic pulmonary vasoconstriction, an effect that is related to the capacity of RBCs to inactivate extraerythrocytically produced NO (9, 13, 28) . These data can also be reconciled with our free Hb data by the observation that inactivation of NO by RBCs is diffusion limited and reduced compared with free Hb, an effect that is magnified by the presence of blood (perfusate) flow (28, 29) . However, it is clear that RBCs even at low concentration did not potentiate inhibition of HPV by nitrite (Figs. 1A and 2D ) and that inhibition of HPV in these experiments was likely related to spontaneous degradation of nitrite to NO in the extraerythrocytic fluid, rather than due to a deoxyreductase effect of intraerythrocytic Hb.
The effects of nitrite on vascular smooth muscle tone may also be dependent on the model studied. The majority of evidence supporting a role for nitrite in RBC-mediated "delivery" of NO comes from tissue baths (aortic rings) (6) . In a dynamic model with flow, the kinetics of deoxyHb reductase activity may be too slow relative to the fast transit of blood through the microvasculature (1-5 s) to permit sufficient NO release to affect the critical upstream resistance vessels. Doyle et al. (16) found that the half time for deoxyHb-mediated nitrite reduction at 25°C is on the order of many hundreds of seconds. This possibility was proposed in response to results from a series of ex vivo experiments reported by Jensen and Agnisola (25) . Isolated, paced trout hearts were perfused with RBCs, to which nitrite was added (400 M). The authors found evidence of nitrite consumption and NO production in the atrial effluent of these preparations but found no effect of nitrite on coronary blood flow in the presence or absence of NO synthase activity. They argued that the bulk of nitrite consumption and NO production may be occurring in the postcapillary circulation. This is unlikely to be a factor in our model, where NO generation from nitrite should occur throughout the circuit given the uniformity of PO 2 . Another difference between dynamic and static systems is that flow may contribute to a diffusion barrier for NO in the unstirred plasma layer between the RBC and the vascular smooth muscle, much as flow appears to contribute to the diffusion barrier that limits inactivation of endothelial-produced NO by intraerythrocytic Hb (27, 28, 30) . The specific mechanism or mechanisms that account for the lack of pulmonary vasodilation by low concentrations of nitrite in the presence of RBCs will require further research.
In conclusion, nitrite at low micromolar concentrations attenuates HPV in buffer-perfused lungs, possibly due to the release of NO rather than a direct effect of nitrite on vascular smooth muscle. However, physiological concentrations of RBCs and free Hb prevent nitrite inhibition of HPV, raising some doubt about any role of RBCs in nitrite-mediated vasodilation in the pulmonary circulation under physiological conditions.
